Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial (Q41522596)

From Wikidata
Jump to navigation Jump to search
scientific article published on 30 July 2015
edit
Language Label Description Also known as
English
Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial
scientific article published on 30 July 2015

    Statements

    Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial (English)
    Dipankar Sircar
    Soumya Chatterjee
    Rajesh Waikhom
    Vishal Golay
    Arpita Raychaudhury
    Suparna Chatterjee
    Rajendra Pandey
    945-950

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit